This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kahl, C. A.
Right arrow Articles by Cornetta, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kahl, C. A.
Right arrow Articles by Cornetta, K.

 Previous Article  |  Next Article 

Journal of Virology, February 2004, p. 1421-1430, Vol. 78, No. 3
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.3.1421-1430.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Human Immunodeficiency Virus Type 1-Derived Lentivirus Vectors Pseudotyped with Envelope Glycoproteins Derived from Ross River Virus and Semliki Forest Virus

Christoph A. Kahl,1 Jon Marsh,1 Joanne Fyffe,2 David A. Sanders,3 and Kenneth Cornetta1,2,4*

Departments of Medical and Molecular Genetics,1 Medicine,2 Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana 46202,4 Department of Biological Sciences, Purdue University, West Lafayette, Indiana 479073

Received 8 July 2003/ Accepted 9 October 2003

Ross River virus (RRV) and Semliki Forest virus (SFV) are two alphaviruses that have a high degree of amino acid homology, as well as a very broad host range. We show here that envelope glycoproteins derived from both viruses can pseudotype human immunodeficiency virus type 1 (HIV-1)-derived lentivirus vectors. Both RRV and SFV glycoproteins considerably expand the host range of the lentivirus vector, and vectors can be efficiently concentrated by ultracentrifugation. A systematic analysis comparing the alphaviral glycoproteins to the vesicular stomatitis virus glycoprotein (VSV-G) revealed that lentivirus vectors incorporate RRV glycoproteins with an efficiency comparable to that of VSV-G. Both pseudotypes have comparable physical titers, but infectious titers with the RRV pseudotype are lower than with VSV-G. Incorporation of SFV glycoproteins into lentivirus vector is less efficient, leading to decreased physical and infectious titers. The transduction rates with VSV-G-, RRV-, and SFV-pseudotyped lentivirus vectors into adherent cell lines can be significantly increased by using a combination of Polybrene and plates coated with CH-296 recombinant fibronectin fragments. Together, our data suggest that RRV and SFV glycoproteins might be suitable as alternatives to VSV-G for pseudotyping lentivirus vectors.


* Corresponding author. Mailing address: Department of Medical and Molecular Genetics, Indiana University, 975 West Walnut St., Indianapolis, IN 46202. Phone: (317) 274-2240. Fax: (317) 278-2262. E-mail: kcornett{at}iupui.edu.


Journal of Virology, February 2004, p. 1421-1430, Vol. 78, No. 3
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.3.1421-1430.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Poluri, A., Ainsworth, R., Weaver, S. C., Sutton, R. E. (2008). Functional Pseudotyping of Human Immunodeficiency Virus Type 1 Vectors by Western Equine Encephalitis Virus Envelope Glycoprotein. J. Virol. 82: 12580-12584 [Abstract] [Full Text]  
  • Strang, B. L., Takeuchi, Y., Relander, T., Richter, J., Bailey, R., Sanders, D. A., Collins, M. K. L., Ikeda, Y. (2005). Human Immunodeficiency Virus Type 1 Vectors with Alphavirus Envelope Glycoproteins Produced from Stable Packaging Cells. J. Virol. 79: 1765-1771 [Abstract] [Full Text]  
  • Kolokoltsov, A. A., Weaver, S. C., Davey, R. A. (2005). Efficient Functional Pseudotyping of Oncoretroviral and Lentiviral Vectors by Venezuelan Equine Encephalitis Virus Envelope Proteins. J. Virol. 79: 756-763 [Abstract] [Full Text]